ArQule Pre-Tax Profit Margin 2006-2018 | ARQL

ArQule pre-tax profit margin from 2006 to 2018. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
ArQule Pre-Tax Profit Margin Historical Data
Date TTM Revenue TTM Pre-Tax Income Pre-Tax Margin
2018-12-31 $0.03B $-0.02B -61.54%
2018-09-30 $0.02B $-0.02B -69.57%
2018-06-30 $0.02B $-0.02B -94.44%
2018-03-31 $0.00B $-0.03B -725.00%
2017-12-31 $0.00B $-0.03B inf%
2017-09-30 $0.00B $-0.03B -2900.00%
2017-06-30 $0.00B $-0.03B -1400.00%
2017-03-31 $0.00B $-0.03B -866.67%
2016-12-31 $0.00B $-0.02B -575.00%
2016-09-30 $0.01B $-0.02B -316.67%
2016-06-30 $0.01B $-0.02B -187.50%
2016-03-31 $0.01B $-0.01B -140.00%
2015-12-31 $0.01B $-0.01B -116.67%
2015-09-30 $0.01B $-0.02B -125.00%
2015-06-30 $0.01B $-0.02B -158.33%
2015-03-31 $0.01B $-0.02B -175.00%
2014-12-31 $0.01B $-0.02B -191.67%
2014-09-30 $0.01B $-0.03B -227.27%
2014-06-30 $0.01B $-0.03B -208.33%
2014-03-31 $0.01B $-0.03B -200.00%
2013-12-31 $0.02B $-0.03B -156.25%
2013-09-30 $0.02B $-0.02B -126.32%
2013-06-30 $0.03B $-0.02B -69.23%
2013-03-31 $0.03B $-0.01B -35.29%
2012-12-31 $0.04B $-0.01B -27.78%
2012-09-30 $0.05B $-0.00B -2.08%
2012-06-30 $0.05B $-0.00B -6.12%
2012-03-31 $0.04B $-0.01B -30.95%
2011-12-31 $0.05B $-0.01B -21.28%
2011-09-30 $0.04B $-0.02B -52.63%
2011-06-30 $0.03B $-0.02B -70.59%
2011-03-31 $0.04B $-0.02B -61.11%
2010-12-31 $0.03B $-0.03B -106.90%
2010-09-30 $0.03B $-0.04B -125.00%
2010-06-30 $0.03B $-0.04B -142.31%
2010-03-31 $0.03B $-0.04B -144.00%
2009-12-31 $0.02B $-0.04B -150.00%
2009-09-30 $0.02B $-0.04B -163.64%
2009-06-30 $0.02B $-0.04B -205.26%
2009-03-31 $0.02B $-0.05B -293.75%
2008-12-31 $0.02B $-0.05B -340.00%
2008-09-30 $0.01B $-0.06B -423.08%
2008-06-30 $0.01B $-0.06B -423.08%
2008-03-31 $0.01B $-0.05B -433.33%
2007-12-31 $0.01B $-0.05B -530.00%
2007-09-30 $0.01B $-0.05B -577.78%
2007-06-30 $0.01B $-0.06B -700.00%
2007-03-31 $0.01B $-0.05B -650.00%
2006-12-31 $0.01B $-0.05B -587.50%
2006-09-30 $0.01B $-0.04B -500.00%
2006-06-30 $0.01B $-0.03B -375.00%
2006-03-31 $0.02B $-0.02B -121.05%
2005-12-31 $0.03B $-0.01B -45.16%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.713B $0.026B
ArQule, Inc. is a biotechnology company engaged in the research and development of next-generation, small-molecule cancer therapeutics. The Company's targeted, broad-spectrum products and research programs are focused on key biological processes that are central to cancer. ArQule's lead clinical-stage products have been generated from two scientific platforms: Cancer Survival Protein modulation and Activated Checkpoint Therapy. The Cancer Survival Protein modulation platform has generated a clinical-stage product that mediates its effects by inhibiting the activity of a molecule known as c-Met, which plays multiple roles in cancer cell growth, survival, invasion, angiogenesis and metastasis. The ACT platform is designed to kill cancer cells selectively while sparing normal cells through direct activation of DNA damage response/checkpoint pathways. The Company's lead ACT program, based on the E2F-1 pathway, is partnered with Roche.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $48.866B 32.47
Takeda Pharmaceutical (TAK) Japan $28.763B 10.64
Grifols (GRFS) Spain $13.022B 15.92
Ionis Pharmaceuticals (IONS) United States $10.380B 32.19
Sage Therapeutics (SAGE) United States $7.864B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.405B 10.60
Neurocrine Biosciences (NBIX) United States $7.366B 474.77
Catalent (CTLT) United States $6.473B 27.10
Nektar Therapeutics (NKTR) United States $5.505B 8.78
Tilray (TLRY) United States $4.865B 0.00
United Therapeutics (UTHR) United States $4.561B 7.76
Taro Pharmaceutical Industries (TARO) Israel $4.165B 13.41
FibroGen (FGEN) United States $4.101B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $3.841B 0.00
Portola Pharmaceuticals (PTLA) United States $2.408B 0.00
PTC Therapeutics (PTCT) United States $2.130B 0.00
USANA Health Sciences (USNA) United States $1.922B 16.12
Heron Therapeutics (HRTX) United States $1.884B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.856B 0.00
Xencor (XNCR) United States $1.836B 0.00
Aerie Pharmaceuticals (AERI) United States $1.814B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.797B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.734B 21.60
Madrigal Pharmaceuticals (MDGL) United States $1.685B 0.00
Endo (ENDP) Ireland $1.656B 2.55
Pacira Pharmaceuticals (PCRX) United States $1.617B 139.82
Zogenix (ZGNX) United States $1.586B 0.00
Corcept Therapeutics (CORT) United States $1.408B 20.45
Tricida (TCDA) United States $1.385B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.321B 0.00
Esperion Therapeutics (ESPR) United States $1.171B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.079B 0.00
TherapeuticsMD (TXMD) United States $1.008B 0.00
Radius Health (RDUS) United States $0.995B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.898B 0.00
Akebia Therapeutics (AKBA) United States $0.781B 0.00
CannTrust Holdings (CTST) Canada $0.767B 0.00
ChemoCentryx (CCXI) United States $0.738B 0.00
Dermira (DERM) United States $0.612B 0.00
Odonate Therapeutics (ODT) United States $0.604B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.595B 0.00
Forty Seven (FTSV) United States $0.583B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.578B 0.00
GlycoMimetics (GLYC) United States $0.562B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.555B 0.00
Collegium Pharmaceutical (COLL) United States $0.495B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.472B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.465B 24.03
TCR2 THERAPTCS (TCRR) United States $0.450B 0.00
KalVista Pharmaceuticals (KALV) United States $0.448B 0.00
Translate Bio (TBIO) United States $0.441B 0.00
Siga Technologies (SIGA) United States $0.437B 0.00
OptiNose (OPTN) United States $0.418B 0.00
Flexion Therapeutics (FLXN) United States $0.408B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.393B 0.00
Aptorum Group (APM) China $0.389B 0.00
Mast Therapeutics (SVRA) United States $0.383B 0.00
ImmunoGen (IMGN) United States $0.375B 0.00
CASI Pharmaceuticals (CASI) United States $0.318B 0.00
Karyopharm Therapeutics (KPTI) United States $0.303B 0.00
Minerva Neurosciences (NERV) United States $0.287B 0.00
Harpoon Therapy (HARP) United States $0.286B 0.00
Lannett Co Inc (LCI) United States $0.283B 2.63
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.280B 10.38
AcelRx Pharmaceuticals (ACRX) United States $0.276B 0.00
Xeris Pharmaceuticals (XERS) United States $0.259B 0.00
Aclaris Therapeutics (ACRS) United States $0.258B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.255B 0.00
Calithera Biosciences (CALA) United States $0.246B 0.00
Dova Pharmaceuticals (DOVA) United States $0.241B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.237B 0.00
Molecular Templates (MTEM) United States $0.236B 0.00
Concert Pharmaceuticals (CNCE) United States $0.227B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.226B 0.00
Aldeyra Therapeutics (ALDX) United States $0.225B 0.00
Ardelyx (ARDX) United States $0.222B 0.00
MEI Pharma (MEIP) United States $0.218B 0.00
Galectin Therapeutics (GALT) United States $0.210B 0.00
Rafael Holdings (RFL) United States $0.206B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.204B 0.00
Affimed (AFMD) Germany $0.203B 0.00
Opexa Therapeutics (ACER) United States $0.200B 0.00
Jounce Therapeutics (JNCE) United States $0.190B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.185B 0.00
Recro Pharma (REPH) United States $0.184B 0.00
Nature's Sunshine Products (NATR) United States $0.183B 190.00
Majesco Entertainment (PTE) United States $0.183B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.179B 0.00
AgeX Therapeutics (AGE) United States $0.178B 0.00
Neon Therapeutics (NTGN) United States $0.176B 0.00
ElectroCore (ECOR) United States $0.176B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.174B 0.00
Redhill Biopharma (RDHL) Israel $0.170B 0.00
Aratana Therapeutics (PETX) United States $0.169B 0.00
Ocular Therapeutix (OCUL) United States $0.165B 0.00
IMV INC (IMV) Canada $0.165B 0.00
Tyme Technologies (TYME) United States $0.163B 0.00
Aquestive Therapeutics (AQST) United States $0.154B 0.00
MediWound (MDWD) Israel $0.143B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.142B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.136B 0.00
China SXT Pharmaceuticals (SXTC) China $0.120B 0.00
ProNAi Therapeutics (SRRA) Canada $0.118B 0.00
Neos Therapeutics (NEOS) United States $0.115B 0.00
Iterum Therapeutics (ITRM) Ireland $0.114B 0.00
Cardiome Pharma (CORV) Canada $0.105B 0.00
Champions Oncology (CSBR) United States $0.097B 0.00
Natural Alternatives (NAII) United States $0.096B 9.37
Oasmia Pharmaceutical AB (OASM) Sweden $0.095B 0.00
Nivalis Therapeutics (ALPN) United States $0.094B 0.00
DURECT (DRRX) United States $0.092B 0.00
Zafgen (ZFGN) United States $0.091B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.091B 0.00
Adherex Technologies (FENC) United States $0.090B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.089B 0.00
Infinity Pharmaceuticals (INFI) United States $0.089B 0.00
Bio Blast Pharma (ENLV) Israel $0.089B 0.00
SCYNEXIS (SCYX) United States $0.085B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.085B 0.00
Otonomy (OTIC) United States $0.082B 0.00
Genocea Biosciences (GNCA) United States $0.078B 0.00
Avenue Therapeutics (ATXI) United States $0.075B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.064B 0.00
Capnia (SLNO) United States $0.064B 0.00
India Globalization Capital (IGC) United States $0.061B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.061B 0.00
CTI BioPharma (CTIC) United States $0.059B 0.00
Forward Pharma (FWP) Denmark $0.056B 0.00
Melinta Therapeutics (MLNT) United States $0.052B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.047B 0.00
Bio-Path Holdings (BPTH) United States $0.045B 0.00
KemPharm (KMPH) United States $0.045B 0.00
Lipocine (LPCN) United States $0.044B 0.00
Mannatechorporated (MTEX) United States $0.042B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.041B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.040B 0.00
BioLineRx (BLRX) Israel $0.039B 0.00
Heat Biologics (HTBX) United States $0.039B 0.00
ContraFect (CFRX) United States $0.038B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.031B 0.00
IsoRay (ISR) United States $0.028B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.028B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.028B 3.62
Achieve Life Sciences (ACHV) United States $0.027B 0.00
Shineco (TYHT) China $0.027B 4.58
PharmAthene (ALT) United States $0.024B 0.00
Jaguar Animal Health (JAGX) United States $0.023B 0.00
Onconova Therapeutics (ONTX) United States $0.023B 0.00
Biomerica (BMRA) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
NOVAN INC (NOVN) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.020B 0.00
Pain Therapeutics (SAVA) United States $0.020B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.019B 0.00
NanoViricides (NNVC) United States $0.019B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.017B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.013B 0.00
Regulus Therapeutics (RGLS) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 3.76
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
RXi Pharmaceuticals (PHIO) United States $0.011B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.010B 0.00
Can-Fite Biopharma (CANF) Israel $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Achaogen (AKAO) United States $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00